Profiles

Keywords
Last Name
Institution

Michael Liptay

Concepts (392)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
64
2019
744
9.140
Why?
Carcinoma, Non-Small-Cell Lung
46
2018
362
6.740
Why?
Pneumonectomy
25
2019
84
3.790
Why?
Sentinel Lymph Node Biopsy
9
2015
20
2.600
Why?
Lymph Nodes
9
2015
84
2.550
Why?
Radiopharmaceuticals
7
2009
59
1.870
Why?
Neoplasm Staging
33
2019
503
1.670
Why?
Thoracic Surgery, Video-Assisted
5
2015
22
1.300
Why?
Mesothelioma
6
2012
17
1.280
Why?
Adenocarcinoma
8
2014
233
1.250
Why?
Esophageal Neoplasms
4
2011
60
1.130
Why?
Lymphatic Metastasis
13
2015
109
1.090
Why?
Carcinoma, Squamous Cell
5
2019
193
1.080
Why?
Neoadjuvant Therapy
8
2015
67
1.060
Why?
Humans
90
2019
29841
1.060
Why?
Bronchoscopy
6
2019
37
1.050
Why?
Pleural Neoplasms
6
2012
13
0.990
Why?
Technetium Tc 99m Sulfur Colloid
4
2009
8
0.970
Why?
Neoplasm Recurrence, Local
8
2017
210
0.910
Why?
Aged
47
2019
9833
0.840
Why?
Small Cell Lung Carcinoma
1
2019
13
0.830
Why?
False Positive Reactions
1
2019
40
0.820
Why?
Unnecessary Procedures
1
2019
30
0.800
Why?
Postoperative Complications
10
2019
1059
0.780
Why?
Male
54
2019
17153
0.760
Why?
Prognosis
17
2017
1025
0.740
Why?
Female
52
2019
17657
0.740
Why?
Mediastinal Neoplasms
2
2009
14
0.700
Why?
Carcinoma, Bronchogenic
1
2015
14
0.650
Why?
Middle Aged
43
2018
11053
0.640
Why?
Anastomosis, Surgical
2
2011
56
0.600
Why?
Gene Expression Regulation, Neoplastic
2
2016
131
0.590
Why?
Thoracic Surgery
6
2019
32
0.570
Why?
Mediastinitis
2
2009
7
0.520
Why?
Breast Neoplasms
2
2007
427
0.520
Why?
Aged, 80 and over
22
2018
5016
0.520
Why?
Pulmonary Diffusing Capacity
3
2016
10
0.510
Why?
Solitary Pulmonary Nodule
3
2015
14
0.510
Why?
Treatment Outcome
21
2017
3788
0.500
Why?
Mediastinal Diseases
1
2012
5
0.500
Why?
Histoplasmosis
1
2012
9
0.500
Why?
Esophagectomy
1
2011
24
0.490
Why?
Practice Management, Medical
1
2011
3
0.490
Why?
Chemoradiotherapy
6
2015
71
0.490
Why?
Adult
27
2017
9591
0.460
Why?
Airway Obstruction
2
2017
22
0.460
Why?
Xanthine Dehydrogenase
1
2010
7
0.450
Why?
Colon
1
2011
146
0.440
Why?
Carbon Monoxide
1
2009
5
0.440
Why?
Survival Analysis
11
2017
390
0.440
Why?
Survival Rate
10
2012
464
0.430
Why?
Aspergillus flavus
1
2009
5
0.430
Why?
Colorectal Neoplasms
2
2009
114
0.430
Why?
Mediastinum
1
2009
8
0.430
Why?
Aspergillosis
1
2009
14
0.430
Why?
Predictive Value of Tests
7
2014
617
0.420
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2015
408
0.410
Why?
Gastrointestinal Stromal Tumors
1
2009
21
0.400
Why?
Carcinoma, Neuroendocrine
1
2008
10
0.400
Why?
Carcinoid Tumor
1
2008
21
0.400
Why?
Risk Assessment
9
2019
794
0.400
Why?
Monitoring, Intraoperative
1
2009
41
0.400
Why?
Diagnosis, Differential
8
2018
466
0.390
Why?
Retrospective Studies
16
2017
3303
0.390
Why?
Neoplasms, Second Primary
1
2008
41
0.380
Why?
Tomography, X-Ray Computed
9
2015
869
0.380
Why?
Device Removal
2
2008
97
0.380
Why?
Catheterization
2
2007
64
0.380
Why?
Pleural Effusion, Malignant
1
2007
6
0.380
Why?
Neoplasms, Multiple Primary
2
2009
40
0.370
Why?
Diagnostic Imaging
1
2009
95
0.370
Why?
Preoperative Care
4
2015
149
0.370
Why?
Genital Neoplasms, Female
1
2007
14
0.370
Why?
Cohort Studies
10
2018
1911
0.370
Why?
Positron-Emission Tomography
1
2008
91
0.360
Why?
Early Detection of Cancer
4
2019
91
0.360
Why?
Combined Modality Therapy
8
2015
467
0.350
Why?
Multiple Pulmonary Nodules
2
2018
9
0.330
Why?
Multivariate Analysis
7
2017
390
0.320
Why?
Immunoassay
2
2018
42
0.320
Why?
Radionuclide Imaging
4
2009
57
0.300
Why?
Follow-Up Studies
10
2014
2017
0.280
Why?
Superior Vena Cava Syndrome
1
2003
8
0.280
Why?
Thoracoscopy
5
2019
19
0.280
Why?
Cesarean Section
1
2003
33
0.280
Why?
Disease-Free Survival
6
2017
245
0.270
Why?
Lymph Node Excision
4
2015
39
0.270
Why?
Insulin-Like Growth Factor Binding Proteins
2
2014
15
0.270
Why?
Thoracic Wall
2
2016
11
0.270
Why?
Lymphoma, Non-Hodgkin
1
2003
59
0.270
Why?
Technetium Compounds
1
2002
1
0.270
Why?
Tin Compounds
1
2002
1
0.270
Why?
Insulin-Like Growth Factor I
2
2014
60
0.260
Why?
Stents
2
2017
157
0.250
Why?
Weight Gain
2
2012
68
0.230
Why?
Biopsy
4
2012
278
0.230
Why?
Pneumonia
2
2019
75
0.220
Why?
Sensitivity and Specificity
4
2018
592
0.220
Why?
Kaplan-Meier Estimate
5
2012
226
0.220
Why?
DNA Methylation
2
2012
154
0.210
Why?
Autoantibodies
2
2010
114
0.210
Why?
Esophagus
2
2011
59
0.210
Why?
Gases
1
2019
6
0.210
Why?
Histiocytoma, Benign Fibrous
1
1999
5
0.210
Why?
Mediastinoscopy
1
2019
5
0.210
Why?
Algorithms
6
2014
414
0.210
Why?
Databases, Factual
6
2019
357
0.210
Why?
Feasibility Studies
3
2009
273
0.200
Why?
Osteosarcoma
1
1999
42
0.200
Why?
History, 20th Century
2
2016
91
0.200
Why?
Intraoperative Period
3
2004
40
0.190
Why?
HLA Antigens
1
2018
20
0.190
Why?
Histocompatibility Antigens Class II
1
2018
17
0.190
Why?
Syndecan-1
1
2018
10
0.190
Why?
Histocompatibility Antigens Class I
1
2018
21
0.190
Why?
Bone Neoplasms
1
1999
114
0.180
Why?
Tracheomalacia
1
2017
5
0.180
Why?
Tracheal Stenosis
1
2017
8
0.180
Why?
Neovascularization, Pathologic
2
2015
70
0.180
Why?
Nerve Growth Factors
1
2018
45
0.180
Why?
Silicones
1
2017
14
0.180
Why?
Sarcoma
2
2009
110
0.180
Why?
Mutagens
1
2016
2
0.180
Why?
Genomic Instability
1
2016
8
0.180
Why?
DNA Repair
1
2016
10
0.180
Why?
Ubiquitin-Protein Ligases
1
2016
45
0.170
Why?
Area Under Curve
3
2014
78
0.170
Why?
Ribs
1
2016
19
0.170
Why?
Risk Factors
7
2019
2549
0.170
Why?
Metformin
1
2016
21
0.170
Why?
Homeostasis
1
2016
104
0.160
Why?
Pulmonary Artery
2
1993
60
0.160
Why?
Proportional Hazards Models
3
2016
379
0.160
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2012
24
0.160
Why?
Cardiac Surgical Procedures
1
2016
94
0.160
Why?
Academic Medical Centers
1
2016
156
0.160
Why?
Hypoglycemic Agents
1
2016
74
0.160
Why?
Heart Diseases
1
2016
97
0.160
Why?
Cardiology
1
2016
96
0.160
Why?
Lung Diseases, Fungal
1
2015
10
0.160
Why?
Mucormycosis
1
2015
7
0.160
Why?
Early Medical Intervention
1
2015
15
0.160
Why?
Disease Progression
4
2014
843
0.150
Why?
Carcinoma
2
2015
83
0.150
Why?
Insulin-Like Growth Factor II
1
2014
10
0.150
Why?
United States
4
2015
2402
0.150
Why?
Periodicals as Topic
1
2015
40
0.150
Why?
Clinical Trials as Topic
2
2012
382
0.150
Why?
Biopsy, Needle
2
2008
119
0.150
Why?
Cytokines
2
2014
344
0.150
Why?
Radiotherapy, Conformal
1
2014
24
0.140
Why?
Thoracotomy
5
2016
34
0.140
Why?
Social Class
1
2014
72
0.140
Why?
Radiotherapy, Adjuvant
5
2011
86
0.140
Why?
Arteriosclerosis
1
1993
18
0.130
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
13
0.130
Why?
Genes, p16
1
2012
5
0.130
Why?
Carcinoma, Small Cell
2
2010
86
0.130
Why?
Diabetes Mellitus, Type 2
1
2016
220
0.130
Why?
Prosthesis Failure
1
2017
520
0.130
Why?
Extracellular Matrix
1
1993
90
0.130
Why?
Esophageal Stenosis
1
2011
6
0.130
Why?
Immunohistochemistry
3
2008
497
0.130
Why?
Macrophages
1
1993
110
0.130
Why?
Stomach
1
2011
19
0.120
Why?
Therapies, Investigational
1
2011
4
0.120
Why?
C-Peptide
1
2011
6
0.120
Why?
Forced Expiratory Volume
2
2009
11
0.120
Why?
Group Practice
1
2011
1
0.120
Why?
Appointments and Schedules
1
2011
15
0.120
Why?
Administrative Personnel
1
2011
9
0.120
Why?
Outpatient Clinics, Hospital
1
2011
14
0.120
Why?
Gene Expression
1
1993
270
0.120
Why?
Translational Medical Research
1
2011
24
0.120
Why?
Young Adult
4
2014
2198
0.120
Why?
Mentors
1
2011
38
0.120
Why?
Time Factors
4
2019
1894
0.120
Why?
Chemotherapy, Adjuvant
4
2011
110
0.120
Why?
Probability
2
2008
107
0.120
Why?
Analysis of Variance
4
2015
369
0.120
Why?
Chemoradiotherapy, Adjuvant
3
2015
21
0.120
Why?
Blood Chemical Analysis
1
2010
17
0.110
Why?
Hematologic Tests
1
2010
6
0.110
Why?
Protein Array Analysis
1
2010
11
0.110
Why?
Length of Stay
6
2016
360
0.110
Why?
Referral and Consultation
1
2011
89
0.110
Why?
PTEN Phosphohydrolase
1
2010
12
0.110
Why?
Apoptosis Regulatory Proteins
1
2010
20
0.110
Why?
Cell Line, Tumor
3
2018
288
0.110
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2010
28
0.110
Why?
Leadership
1
2011
96
0.110
Why?
Rhabdomyosarcoma
1
2009
7
0.110
Why?
Pleura
2
2007
7
0.110
Why?
Tumor Suppressor Proteins
1
2010
41
0.110
Why?
Antineoplastic Agents
4
2014
314
0.110
Why?
Models, Statistical
1
2010
140
0.110
Why?
Adolescent
4
2010
2591
0.110
Why?
Fibrosis
1
2009
55
0.110
Why?
Animals
5
2010
5125
0.100
Why?
Antifungal Agents
1
2009
42
0.100
Why?
Poland Syndrome
1
2009
1
0.100
Why?
Thoracoplasty
1
2009
1
0.100
Why?
Anti-Arrhythmia Agents
1
2010
104
0.100
Why?
Cause of Death
1
2009
73
0.100
Why?
Soft Tissue Neoplasms
1
2009
39
0.100
Why?
Carcinoma, Large Cell
1
2009
18
0.100
Why?
Smoking
1
2010
195
0.100
Why?
Silicone Elastomers
1
2008
3
0.100
Why?
Bronchial Fistula
1
2008
3
0.100
Why?
Esophageal Fistula
1
2008
3
0.100
Why?
Esophageal Perforation
1
2008
10
0.100
Why?
Surgical Wound Dehiscence
1
2008
12
0.100
Why?
Prosthesis Implantation
1
2008
43
0.090
Why?
Fluorodeoxyglucose F18
1
2008
29
0.090
Why?
Intraoperative Care
1
2008
58
0.090
Why?
Esophageal Achalasia
1
2007
22
0.090
Why?
Drainage
1
2007
54
0.090
Why?
Botulinum Toxins, Type A
1
2007
34
0.090
Why?
Age Factors
4
2014
912
0.090
Why?
Healthcare Disparities
1
2008
75
0.090
Why?
Atrial Fibrillation
1
2010
191
0.090
Why?
Prospective Studies
5
2011
1809
0.090
Why?
Neoplasm Invasiveness
2
2017
104
0.090
Why?
Delivery of Health Care
1
2008
110
0.090
Why?
Sepsis
1
2008
153
0.080
Why?
Palliative Care
1
2007
128
0.080
Why?
Radiotherapy Dosage
3
2015
146
0.080
Why?
Muscle, Skeletal
1
2009
368
0.080
Why?
Carboplatin
3
2011
50
0.080
Why?
Vinblastine
1
2004
15
0.080
Why?
Paclitaxel
3
2011
77
0.070
Why?
Deoxycytidine
1
2004
49
0.070
Why?
Radiography
2
2013
714
0.070
Why?
Societies, Medical
2
2019
202
0.070
Why?
Patient Care Planning
1
2003
58
0.070
Why?
Reoperation
1
2008
911
0.070
Why?
ROC Curve
2
2014
154
0.070
Why?
Hypertension, Pulmonary
2
1993
26
0.070
Why?
Magnetic Resonance Imaging
1
2009
1220
0.070
Why?
Illinois
2
2014
265
0.070
Why?
Heart Transplantation
2
1993
52
0.060
Why?
Tomography, Emission-Computed
2
1999
13
0.060
Why?
Graft Rejection
2
1993
85
0.060
Why?
Pregnancy
1
2003
443
0.060
Why?
Lung Diseases
2
1999
55
0.060
Why?
Radiography, Thoracic
2
2012
38
0.060
Why?
Etoposide
2
2011
64
0.060
Why?
Health Services Accessibility
2
2014
106
0.060
Why?
Chicago
2
2016
916
0.050
Why?
Sarcoma, Small Cell
1
1999
1
0.050
Why?
Aging
1
2010
1484
0.050
Why?
Anesthesia, Epidural
1
1999
29
0.050
Why?
Plasmacytoma
1
1999
19
0.050
Why?
Sarcoma, Ewing
1
1999
9
0.050
Why?
Electrocardiography
3
2003
227
0.050
Why?
Bupivacaine
1
1999
55
0.050
Why?
Pilot Projects
1
2000
425
0.050
Why?
Anesthetics, Local
1
1999
85
0.050
Why?
Radiation Injuries
1
1999
44
0.050
Why?
Case-Control Studies
2
2010
684
0.050
Why?
Postoperative Care
1
1999
138
0.050
Why?
Endoscopy
2
1997
173
0.050
Why?
Remission Induction
2
2010
125
0.050
Why?
Dilatation
1
2017
12
0.050
Why?
DNA End-Joining Repair
1
2016
1
0.040
Why?
Amino Acid Motifs
1
2016
20
0.040
Why?
Protein Transport
1
2016
42
0.040
Why?
DNA Damage
1
2016
33
0.040
Why?
Ubiquitin
1
2016
34
0.040
Why?
History, 21st Century
1
2016
39
0.040
Why?
Carcinogenesis
1
2016
24
0.040
Why?
History, 19th Century
1
2016
76
0.040
Why?
Procollagen
2
1993
10
0.040
Why?
Diffusion of Innovation
1
2016
42
0.040
Why?
Pneumonia, Bacterial
1
2016
15
0.040
Why?
Muscle, Smooth, Vascular
2
1993
28
0.040
Why?
Tracheostomy
1
2016
27
0.040
Why?
Incidence
2
2010
813
0.040
Why?
Education, Medical, Graduate
1
2016
82
0.040
Why?
Neoplasm, Residual
1
2015
10
0.040
Why?
Pain, Postoperative
1
1999
293
0.040
Why?
Phenotype
1
2016
360
0.040
Why?
Intubation, Intratracheal
1
2016
65
0.040
Why?
Minnesota
1
2014
12
0.040
Why?
Diabetes Mellitus
1
2016
131
0.040
Why?
Actuarial Analysis
1
2014
16
0.040
Why?
Induction Chemotherapy
1
2014
14
0.040
Why?
Academies and Institutes
1
2014
11
0.040
Why?
Cancer Care Facilities
1
2014
6
0.040
Why?
Arrhythmias, Cardiac
1
1996
168
0.040
Why?
Propensity Score
1
2014
51
0.040
Why?
Mutation
1
2016
445
0.040
Why?
Radiotherapy, Intensity-Modulated
1
2014
40
0.040
Why?
Patient Readmission
1
2015
111
0.040
Why?
Internship and Residency
1
2016
182
0.030
Why?
Chemokine CCL3
1
2013
12
0.030
Why?
Granuloma
1
2013
15
0.030
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
15
0.030
Why?
Signal Transduction
1
2016
563
0.030
Why?
Chemokine CXCL12
1
2013
9
0.030
Why?
Fibronectins
1
1993
32
0.030
Why?
Collagen
1
1993
111
0.030
Why?
Coronary Circulation
1
1993
49
0.030
Why?
Pulmonary Circulation
1
1992
7
0.030
Why?
Respiratory Mechanics
1
1992
10
0.030
Why?
Reperfusion Injury
1
1992
9
0.030
Why?
Interleukin-10
1
2013
42
0.030
Why?
Lung
2
2010
164
0.030
Why?
Respiratory Tract Infections
1
2013
53
0.030
Why?
Ischemia
1
1992
32
0.030
Why?
Registries
1
2014
195
0.030
Why?
Telemetry
1
1992
15
0.030
Why?
Logistic Models
1
2014
478
0.030
Why?
Interleukin-6
1
2013
116
0.030
Why?
Decision Support Techniques
1
2012
54
0.030
Why?
Epigenesis, Genetic
1
2012
86
0.030
Why?
Prevalence
1
2014
533
0.030
Why?
Tumor Necrosis Factor-alpha
1
2013
227
0.030
Why?
Digestive System Surgical Procedures
1
2011
27
0.030
Why?
Reproducibility of Results
1
2014
857
0.030
Why?
Medical Oncology
1
2011
39
0.030
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.030
Why?
Serum
1
2010
8
0.030
Why?
Tandem Mass Spectrometry
1
2010
22
0.030
Why?
Choice Behavior
1
2011
62
0.030
Why?
Antibodies, Neoplasm
1
2010
18
0.030
Why?
Monomeric GTP-Binding Proteins
1
2010
4
0.030
Why?
Death-Associated Protein Kinases
1
2010
5
0.030
Why?
DNA Modification Methylases
1
2010
6
0.030
Why?
DNA Repair Enzymes
1
2010
9
0.030
Why?
Antigens, Neoplasm
1
2010
56
0.030
Why?
Immunoenzyme Techniques
1
2010
55
0.030
Why?
In Situ Hybridization, Fluorescence
1
2010
43
0.030
Why?
Cadherins
1
2010
37
0.030
Why?
CpG Islands
1
2010
48
0.030
Why?
Medical Records
1
2010
40
0.030
Why?
Neoplasm Proteins
1
2010
60
0.030
Why?
Promoter Regions, Genetic
1
2010
103
0.030
Why?
Proteomics
1
2010
58
0.030
Why?
Antigens, CD
1
2010
106
0.030
Why?
Fluorouracil
1
2009
89
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2010
82
0.030
Why?
Cisplatin
1
2009
107
0.030
Why?
Carcinoma, Renal Cell
1
2009
76
0.030
Why?
Kidney Neoplasms
1
2009
109
0.020
Why?
Surgical Flaps
1
2009
54
0.020
Why?
Sutures
1
2008
42
0.020
Why?
Dogs
3
1993
284
0.020
Why?
Esophageal Diseases
1
2007
7
0.020
Why?
Ulcer
1
2007
7
0.020
Why?
Video Recording
2
1997
49
0.020
Why?
Maximum Tolerated Dose
1
2004
22
0.020
Why?
Statistics, Nonparametric
1
2004
162
0.020
Why?
Drug Administration Schedule
1
2004
265
0.020
Why?
Respiratory Function Tests
1
2003
35
0.020
Why?
European Continental Ancestry Group
1
2008
593
0.020
Why?
Dose-Response Relationship, Drug
1
2004
524
0.020
Why?
Weight Loss
1
2003
106
0.020
Why?
Transplantation, Heterotopic
2
1993
13
0.020
Why?
Health Status
1
2003
250
0.020
Why?
African Americans
1
2008
739
0.010
Why?
Vital Capacity
1
1999
7
0.010
Why?
Pruritus
1
1999
17
0.010
Why?
Fentanyl
1
1999
23
0.010
Why?
Urinary Retention
1
1999
11
0.010
Why?
Cardiovascular Diseases
1
2003
370
0.010
Why?
Narcotics
1
1999
33
0.010
Why?
Thoracic Neoplasms
1
1997
9
0.010
Why?
Abdominal Neoplasms
1
1997
13
0.010
Why?
Pericardial Window Techniques
1
1996
3
0.010
Why?
Pain Measurement
1
1999
470
0.010
Why?
Treatment Failure
1
1997
186
0.010
Why?
Morbidity
1
1996
71
0.010
Why?
Radiotherapy
1
1995
67
0.010
Why?
Neoplasm Metastasis
1
1995
146
0.010
Why?
Recurrence
1
1995
383
0.010
Why?
Desmin
1
1993
2
0.010
Why?
Staining and Labeling
1
1993
27
0.010
Why?
Actins
1
1993
60
0.010
Why?
Cyclosporine
1
1993
19
0.010
Why?
Acid-Base Equilibrium
1
1992
5
0.010
Why?
Blood Gas Analysis
1
1992
11
0.010
Why?
Pulmonary Alveoli
1
1992
24
0.010
Why?
Capillary Permeability
1
1992
28
0.010
Why?
Body Temperature
1
1992
74
0.010
Why?
Hemodynamics
1
1992
105
0.010
Why?
Reactive Oxygen Species
1
1992
124
0.010
Why?
Electrodes, Implanted
1
1992
49
0.010
Why?
Antibodies, Monoclonal
1
1993
309
0.010
Why?
Monitoring, Physiologic
1
1992
101
0.010
Why?
Myocardium
1
1992
178
0.010
Why?
Immunosuppressive Agents
1
1992
167
0.010
Why?
Liptay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_